OCUL

5.5704.95%
PU

Pravin U. Dugel

Executive Chairman, President & CEO

Dr. Pravin U. Dugel, M. D. has been Executive Chairman of Ocular Therapeutix, Inc. since February 21, 2024 and also serves as its Chief Executive Officer and President since April 15, 2024. He served as President at Iveric bio, Inc since May 01, 2021 until October 2023 and served as its Executive Vice President and Chief Strategy and Business Officer since April 01, 2020 until May 01, 2021. He served as an Independent Director at Oculis Holding AG since March 2023 until 2024. He serves as an Advisor of Kubota Pharmaceutical Holdings Co. Ltd. (formerly Acucela Inc.). He is Director of IVERIC bio, Inc. from January 1, 2023. Dr. Dugel had been Managing Partner of Retinal Consultants of Arizona from 2004 to 2019. Dr. Dugel serves as Member of Advisory Board at Acucela Inc. He also practices as part of the physician group at Retinal Consultants of Arizona, one of the nation's top teams of retinal specialists. Throughout his career, he has served as Principal Investigator or Co-investigator on more than 35 research trials, including several in collaboration with the National Eye Institute. He has been Independent Director of Aerpio Pharmaceuticals, Inc. since March 2017. Dr. Dugel serves as Member of Medical Advisory Board at TrueVision Systems, Inc. He had been a Member of Retina Clinical Advisory Board at Graybug Vision, Inc. since June 21, 2016. Dr. Dugel serves as a Member of the Scientific Advisory Board at MacuSight, Inc. Alcon Surgical, Genentech and Novartis. He had been Member of Clinical Advisory Board at Opthea Limited since December 2014. He served as a Director of Aadi Bioscience, Inc. until August 2021. An active participant in the ophthalmology community, Dr. Dugel serves as a Member of several professional organizations including the American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, American Medical Association and American Society of Retinal Surgeons, among others. He serves on the Board of Directors of the Asia Pacific Vitreoretinal Society. He was a Founding Member of the Spectra Eye Institute. He was a Clinical Professor of USC Roski Eye Institute, Keck School of Medicine at University of Southern California. Dr. Dugel is a prolific Author with more than 50 peer-reviewed articles and 15 book chapters to his credit. Dr. Dugel has authored more than 200 papers and 35 book chapters and has been invited to give prestigious named lectures at marquis medical meetings and to serve as a visiting professor at universities worldwide, including in Japan, India, Nepal, China, Malaysia, Egypt, the United Kingdom, France, Germany, Austria, Italy, Poland, Denmark, Norway, the Czech Republic, Canada and Australia. Dr. Dugel is internationally recognized as a major clinical researcher and has been a principal investigator in over 100 multicenter clinical trials. His research and educational contributions earned him the prestigious Honor Award, Senior Honor Award and Lifetime Achievement Award from the American Academy of Ophthalmology (AAO). He has been elected and previously served as the Retina Subspecialty Day Board Chairman for the American Academy of Ophthalmology Annual Meeting, as a member of the Board of Directors of the largest retina society in the United States, the American Society of Retina Specialists (ASRS) and the largest retina society in Europe, EURETINA. Additionally, he has been elected to the Retina Society, Macula Society and the Retina Hall of Fame. He has received numerous awards including amongst others, the Heed Foundation Fellowship Award, The Ronald G. Michels Surgical Fellowship Award, AAO Senior Honor Award, ASRS Honor Award and the AAO Secretariat Award. He completed his medical retina fellowship at the Bascom Palmer Eye Institute and his surgical retina fellowship at the Doheny Eye Institute, where he was the Resident Director. Dr. Dugel Received his M. D. From Ucla School of Medicine and his BA in Comparative Literature and Molecular Biology from Columbia University. He attended Harrow School in London, England. He completed his medical retina fellowship at the Bascom Palmer Eye Institute and his surgical retina fellowship at the USC Eye Institute, where he was elected to serve on the faculty as the Resident Director. He then completed his residency in ophthalmology at the Doheny Eye Institute, UCLA School of Medicine.

Positions